Labopharm's Once-Daily Tramadol Approved in South Korea and... (harm has entered into for other European...)

Labopharm's Once-Daily Tramadol Approved in South Korea and Australia

Date:2/13/2008

harm has entered into for other European markets. Labopharm is also eligible to receive additional payments upon the achievement of certain milestones.

Labopharm has submitted a marketing application for regulatory approval of its once-daily formulation of tramadol to the Ministry of Health in Turkey. The Company expects to receive approval in early 2009.

For the 12-month period ended September 2007, sales of tramadol products in Turkey were 7.1 million standard units, representing a compounded annual growth rate over the previous five 12-month periods of 35%.

About Dr. F. Frik Ilac San. Ve Tic. A. S.

Dr. F. Frik Ilac San. Ve Tic. A. S. focuses on the registration, sales and marketing of value added pharmaceutical products in Turkey, as well as some foreign markets. The Company has more than 225 sales representatives promoting products in the central nervous system, musculo-skeletal, respiratory, gastrointestinal and other treatment areas.

About Labopharm Inc.

Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is being commercially launched in key markets globally. The Company also has a robust pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become a fully integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize its own products. For more information, please visit http://www.labopharm.com.

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors, in
'/>"/>

SOURCE Labopharm Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
2. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
3. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
4. ISTA Pharmaceuticals Submits New Drug Application for Xibrom(TM) QD (once-daily)
5. Once-Daily Exjade(R) Shown to Remove Toxic Iron From the Heart and Liver, According to Data Presented at ASH
6. Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
7. Labopharm appeals FDAs decision on once-daily tramadol
8. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
9. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
10. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
11. Cipher provides CIP-TRAMADOL ER regulatory update

Post Your Comments:

(Date:12/16/2009)... -- For wounded U.S. servicemen and women ... D.C., the holidays can be a particularly difficult time. ... rely more than ever on the healing power of ... home just got easier for Walter Reed patients as ... will provide hundreds of minutes of holiday talk time ...

(Date:12/16/2009)... second, possibly deadly, attack is long-term goal, researchers say ... have developed a tool to predict whether a patient ... a first stroke. , "This is an important new ... a second stroke soon after a first stroke are ... Hakan Ay, of Massachusetts General Hospital and Harvard Medical ...

(Date:12/16/2009)... help ease health and environmental concerns about the emerging ... changing the behavior of nanoparticles in municipal sewage treatment ... study was published in ACS, journal Environmental Science ... Centre for Ecology and Hydrology and colleagues note that ... particles less than 1/1000th the width of a ...

(Date:12/16/2009)... Coalition Urges Lawmakers to Ensure and Encourage Access to Quality, Cost-Effective ... ... -- For months, members of Congress have debated the best ways ... part of health care reform. An important part of the ... full range of health care providers besides doctors of medicine (MDs) ...

(Date:12/16/2009)... Therapy or NSRTSM is found very effective in the alleviation ... asthma, migraines, chronic fatigue and a wide array of skin ... using this holistic therapy including over 50 branded BioVeda Health ... ... MN (Vocus) December 14, 2009 -- BioVeda Health and Wellness ...

Breaking Medicine News(10 mins):Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2 Health News:New Stroke Tool May Predict Early Recurrence 2 Health News:Behavior modification could ease concerns about nanoparticles 2 Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 2 Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 3 Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 4 Health News:Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs 5 Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 2 Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 3 Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 4 Health News:BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening 5

[0] Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital [0] New Stroke Tool May Predict Early Recurrence [0] Behavior modification could ease concerns about nanoparticles [1] Coalition for Patients' Rights: Access to Broad Range of Health Care Providers Critical to Lowering Costs [0] BioVeda Health and Wellness Center of Chanhassen, MN Announces Its Grand Opening

... Today, ReCellular announced a new,cell-phone recycling campaign to ... is to raise a minimum of $50,000 for the ... "In 1991, we started with a simple mission ... and environmentally responsible," says Chuck,Newman, founder and CEO of ...

... an urgent need for greater coordination and harmonisation between ... from large numbers of people that can be used ... To enable this, there should also be closer coordination ... as increased and sustained funding for biobanks. This will ...

... University] Magnetic resonance imaging (MRI) can be a ... body without resorting to surgery. MRI scans use pulses ... identify different types of tissue in the body, distinguishing ... , Scientists have found that magnetic nanoparticles can be ...

... for Storage and to Advance VSEL Research, NEW ... ),which is pioneering the pre-disease collection, processing and long-term,storage ... announced that,it has signed a collection center agreement with ... Robin Smith, MD MBA, NeoStem,s Chairman and Chief ...

... CARLSBAD, Calif., May 27 Isis,Pharmaceuticals, Inc. (Nasdaq: ... receive,$4.6 million dollars from Alnylam Pharmaceuticals, Inc. (Nasdaq: ... fees in the recently announced transaction,between Takeda Pharmaceutical ... potential to receive portions of future milestone and ...

... save time and money accepting automatic ... direct from resident bank accounts, PORTLAND, Ore., ... added PaySimple, the leading provider of on-demand electronic ... help simplify resident billing,and collection for assisted living, ...

Other Medicine News:Health News:ReCellular and American Red Cross Announce Cell-Phone Recycling Campaign 2 Health News:ReCellular and American Red Cross Announce Cell-Phone Recycling Campaign 3 Health News:Europe's biobanks need urgent coordination -- scientists say 2 Health News:Brown chemists create cancer-detecting nanoparticles 2 Health News:NeoStem Signs Stem Cell Collection Agreement With University of Louisville Hospital 2 Health News:NeoStem Signs Stem Cell Collection Agreement With University of Louisville Hospital 3 Health News:Isis to Receive $4.6 Million From Alnylam 2 Health News:Isis to Receive $4.6 Million From Alnylam 3 Health News:Vigilan Offers PaySimple to Simplify Resident Billing and Collection 2

ReCellular and American Red Cross Announce Cell-Phone Recycling Campaign Europe's biobanks need urgent coordination -- scientists say Brown chemists create cancer-detecting nanoparticles NeoStem Signs Stem Cell Collection Agreement With University of Louisville Hospital Isis to Receive $4.6 Million From Alnylam Vigilan Offers PaySimple to Simplify Resident Billing and Collection

(Date:12/16/2009)... International, well-known,scientific experts were ... (80 mg/day),data presented as "extremely promising."[1] ... and clinicians critically reviewed these data.,These ... generic lipid-modifying,treatments, fenofibrate and bezafibrate, in ... in patients with metabolic syndrome,and type ...

(Date:12/16/2009)... 16 Verathon®, maker of BladderScan® ... that portable bladder volume ultrasound is now ... for the Prevention of Catheter-Associated Urinary Tract ... introduced in early November 2009, replace the ... The guidelines are located on the ...

(Date:12/16/2009)... 16 Greenway Medical Technologies, Inc. today ... record (EHR), practice management and interoperability solution, Prime ... awards in the annual 2009 Top 20 ... Services report. ,, For practices having between ... was named Best in KLAS in ambulatory EMR ...

[0] International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia [0] New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound [0] Greenway Medical Technologies' PrimeSuite Wins Three Best in KLAS Awards

... Address Skin Hardening Affects of the,Devastating Disease, ... are studying the effects of an anti-cancer drug ... rheumatic disease,that leads to hardening and tightening of ... 300,000 people in the United States and,can often ...

... demonstrates BSGI is ... both patient and cost effective., NEWPORT NEWS, ... Bertrand, Director of Breast Imaging at Solis Bertrand Breast,Center in ... (BSGI) as an adjunctive procedure in breast,diagnostics; specifically demonstrating BSGI ...

Other Medicine Technology:Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients 2 Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics 2 Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics 3

Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics

EDM Ventricular Drainage Kit, with Drip Chamber with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in ...

Lumbar External Drainage System (LED) with Touhy needle is indicated for temporary access to the Lumbar Subarachnoid region as a means of draining cerebral spinal fluid (CSF) in order to reduce incre...

Monitorr ICP external CSF drainage and monitoring system with patient line one way valve....

Skull Traction Tongs for cervical vertebra extension, adjustable pins, eliminates need for preliminary drilling, large pattern, complete with wrench...

Medicine Products:

EDM Ventricular Drainage Kit, with Drip Chamber Lumbar External Drainage System (LED)Monitorr ICP External CSF Drainage and Monitoring System Skull Traction Tongs

Labopharm's Once-Daily Tramadol Approved in South Korea and...(harm has entered into for other European...),Health